Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Malignant mesothelioma that arises from the pleura. It is characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor.
Biomarker and diagnostic research for pleural biphasic mesothelioma has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
46 publications have been identified in PubMed for pleural biphasic mesothelioma. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (24%), and Clinical Trial Publication (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:35 PM UTC
Laboratory research | 11 | 24% |
Clinical study results | 8 | 17% |
Disease patterns and progression | 4 | 9% |
Testing and diagnosis research | 3 | 7% |
Research summaries | 3 | 7% |
New treatment approaches | 2 | 4% |
Gagnon MF (2026). [PMID: 41967647](https://pubmed.ncbi.nlm.nih.gov/41967647/). *Hum Pathol*. [Basic Science / Preclinical]
Li H (2026). [PMID: 42107977](https://pubmed.ncbi.nlm.nih.gov/42107977/). *Arch Pathol Lab Med*. [Case Report / Case Series]
Cayuela L (2026). [PMID: 41862332](https://pubmed.ncbi.nlm.nih.gov/41862332/). *Arch Bronconeumol*. [Epidemiology / Natural History]
Gulati S (2026). [PMID: 41638523](https://pubmed.ncbi.nlm.nih.gov/41638523/). *The Annals of thoracic surgery*. [Case Report / Case Series]
Ocejo A (2026). [PMID: 41938083](https://pubmed.ncbi.nlm.nih.gov/41938083/). *JTO Clin Res Rep*. [Basic Science / Preclinical]
Al Achkar Z (2026). [PMID: 42026555](https://pubmed.ncbi.nlm.nih.gov/42026555/). *BMC Pulm Med*. [Review / Meta-Analysis]
Janssens E (2026). [PMID: 41534436](https://pubmed.ncbi.nlm.nih.gov/41534436/). *Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie*. [Case Report / Case Series]
Nakai T (2026). [PMID: 41808711](https://pubmed.ncbi.nlm.nih.gov/41808711/). *Translational lung cancer research*. [Case Report / Case Series]
Findley J (2026). [PMID: 41721215](https://pubmed.ncbi.nlm.nih.gov/41721215/). *Cytopathology : official journal of the British Society for Clinical Cytology*. [Case Report / Case Series]
Zhao T (2026). [PMID: 42237856](https://pubmed.ncbi.nlm.nih.gov/42237856/). *Int J Surg Pathol*. [Case Report / Case Series]